Feb 27 (Reuters) - Sycamore Partners plans to split Walgreens' WBA.O three main businesses into separate units with distinct capital structures after taking the pharmacy chain private, the Financial Times reported on Thursday, citing people familiar with the matter.
Walgreens has reportedly been in talks to sell itself to private equity firm Sycamore, but no deal has been reached yet.
Shares of Walgreens rose nearly 7.8% to $11.9 in premarket trading.
The financing of the take-private deal is not expected to be an obstacle, according to the report. Stefano Pessina, executive chair of Walgreens, is expected to maintain a significant share of the company as part of the deal, it added.
Sycamore declined to comment to a Reuters request, while Walgreens did not immediately respond.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.